NASDAQ: NGNE 31.15%
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
OTC: ACXIF 21.95%
Underperform Recommendation Issued On ACXIF By RBC Capital
NASDAQ: PRAA 32.17%
PRA Group (PRAA) Q4 2025 Earnings Call Transcript
OTC: GHVNF 21.76%
Top 5 Canadian Mining Stocks This Week: Euro Manganese Gains 134 Percent
NYSE: KORE 77.39%
KORE Reports Third Quarter 2025 Results
NASDAQ: ONMD 72.9%
OneMedNet Stock Soars 90% Following Real-World Data Platform Launch
NASDAQ: NGNE 21.95%
NASDAQ: ACXIF 21.95%
NASDAQ: PRAA 21.95%
NASDAQ: GHVNF 21.95%
NASDAQ: KORE 21.95%
